P602: Risankizumab levels but not IL22 are significantly correlated and predictive of clinical and biochemical remission in Crohn@E@s disease.ECCO'24Year: 2024
Authors: Roblin, X.(1)*;barrau, M.(2);Duru, G.(3);Nancey, S.(4);Paul, S.(5);
(1)CHU Saint Etienne - Hospital Nord, Department of Gastroenterology and Hepatology- Inserm- CIC1408, Saint Priest en Jarez, France;(2)CHU Saint Etienne, gastronetrology, Saint Etiennne, France;(3)CHU Saint Etienne, statstic, Saint Etiennne, France;(4)CHU Lyon, Gastroenterology, Lyon, France;(5)CHU Saint Etienne, Immunology, Saint Etiennne, France;
P603: Comparison of the safety and efficacy of ustekinumab and vedolizumab in patients with Crohn’s disease. - A systematic review and meta-analysis of propensity score matched cohort studies.ECCO'24Year: 2024
Authors: Bodini, G.(1);Calabrese, F.(1)*;Pasta, A.(1);Marabotto, E.(1);Furnari, M.(1);Demarzo, M.G.(2);Giannini, E.G.(1);
(1)University of Genoa, Gastroenterology Unit- Department of Internal Medicine, Genoa, Italy;(2)University of Genoa- IRCCS San Martino Hospital, Unit of Gastroenterology and Interventistic Endoscopy, Genoa, Italy;
P607: Increased rates of fractures and malignancy in elderly onset IBD in SingaporeECCO'24Year: 2024
Authors: Tan, C.K.(1)*;Ong, J.(1);Ang, T.L.(1);Salazar, E.(2);Tan, M.(2);Lim, C.T.(2);Tay, S.W.(2);Tan, Y.Y.(2);Chan, W.(2);
(1)Changi General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;(2)Singapore General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore;
P608: Steroid use in a high proportion of IBD patients – first results from the Spanish cohort of the IBD-DICE studyECCO'24Year: 2024
Authors: Gomollón Garcia, F.(1)*;Vega Villaamil, P.(2);Romero Cara , P.(3);Michelena de Gorósabel , N.(4);Benyaich El Belghami, G.K.(4);Huguet Malavés , J.M.(5);
(1)Hospital Clínico Universitario “Lozano Blesa”- IIS Aragón- Facultad de Medicina de Zaragoza- CIBEREHD, Gastroenterology, Zaragoza, Spain;(2)Complexo hospitalario Universitario de Ourense, Gastroenterology, Ourense, Spain;(3)Hospital Regional Universitario de Málaga, Gastroenterology, Malaga, Spain;(4)Abbvie, Medical, Madrid, Spain;(5)Hospital general Universitario de Valencia., Gastroenterology, Valencia, Spain;
P609: Artificial intelligence in the image recognition of pouchoscopies in patients who have undergone restorative proctocolectomy with ileal pouch anal-anastomosis (IPAA).ECCO'24Year: 2024
Authors: Saifi , M.(1)*;Schmitz , D.(2);Ringwald , F.(3);Eisenmann , U.(3);Rudi , J. (4);Kienle , P.(1);
(1)Theresienkrankenhaus und Diako gGmbH, General and Visceral Surgery, Mannheim, Germany;(2)Helios Klinik Schwerin, Klinik für Gastroenterologie und Infektiologie, Schwerin, Germany;(3)Universitätsklinikum Heidelberg, Institut für Medizinische Informatik, Heidelberg, Germany;(4)Theresienkrankenhaus und Diako gGmbH, Klinik für Gastroenterologie, Onkologie und Diabetologie, Mannheim, Germany;
P610: Ustekinumab demonstrates superior treatment persistence over anti-TNF in Crohn’s disease patients previously treated with vedolizumabECCO'24Year: 2024
Authors: Chiu, H.Y.(1)*;Le, P.H.(2);Yeh, P.J.(3);Kuo, C.J.(2);Lai, M.(3);Wu, R.C.(4);Chen, C.M.(5);Chiu, C.T.(2);Chiu, C.H.(6);Su, M.(7);Pan, Y.B.(8);
(1)Chang Gung University, School of Medicine, Taoyuan City, Taiwan;(2)Chang Gung Memorial Hospital- Linkou Branch, Department of Gastroenterology and Hepatology, Taoyuan City, Taiwan;(3)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Gastroenterology- Department of Pediatrics, Taoyuan City, Taiwan;(4)Chang Gung Memorial Hospital- Linkou Branch, Department of Anatomic Pathology, Taoyuan City, Taiwan;(5)Chang Gung Memorial Hospital- Linkou Branch, Department of Medical Imaging and Interventions, Taoyuan City, Taiwan;(6)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Infectious Diseases- Department of Pediatrics, Taoyuan City, Taiwan;(7)New Taipei City Municipal Tucheng Hospital, Department of Gastroenterology and Hepatology, New Taipei City, Taiwan;(8)Chang Gung Memorial Hospital- Linkou Branch, Biostatistical Section- Clinical Trial Center, Taoyuan City, Taiwan;
P611: Relation between AntiTNF levels during the induction and clinical and radiological outcomes in perianal Crohn´s diseaseECCO'24Year: 2024
Authors: Amiama Roig, C.(1)*;Suarez Ferrer, C.(1);Martin Arranz, E.(1);Rueda Garcia, J.L.(1);Sánchez Azofra, M.(1);Poza Cordón, J.(1);Gonzalez Diaz, I.(1);Amor Costa, C.(1);Martín-Arranz, M.D.(1,2);
(1)La Paz University Hospital, Gastroenterology and Hepatology Department, Madrid, Spain;(2)La Paz University Hospital, Gastroenterology and Hepatology Department. - Hospital La Paz Institute for Health Research - IdiPAZ, Madrid, Spain;
P612: Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD studyECCO'24Year: 2024
Authors: Ribaldone, D.G.(1)*;Parisio, L.(2);Variola, A.(3);Bossa, F.(4);Castiglione, F.(5);Marzo, M.(6);Piazza, N.(7);Aratari, A.(8);Savarino, E.V.(9);Bodini, G.(10);Mastronardi, M.(11);Micheli, F.(12);Mazzuoli, S.(13);Ascolani, M.(14);Viganò, C.(15);Cappello, M.(16);Bezzio, C.(17);Ciccocioppo, R.(18);Scardino, G.(19);Sarli, E.(20);Pugliese, D.(2);Scaldaferri, F.(2);Napolitano, D.(2);Todeschini, A.(3);Geccherle, A.(3);Colaci, N.(21);Guerra, M.(4);Annese, M.(4);Testa, A.(5);Caiazzo, A.(5);Conforti, F.S.(7);Festa, S.(8);Lorenzon, G.(9);Marra, A.(11);Magiotta, A.(12);Baccini, F.(12);Amato, A.(22);Vernero, M.(1);Caprioli, F.(23);Caviglia, G.P.(1);
(1)University of Turin, Department of Medical Sciences, Turin, Italy;(2)Fondazione Policlinico Universitario A. Gemelli IRCCS- Università Cattolica del Sacro Cuore, CEAMD-IBD Unit, Rome, Italy;(3)IRCCS Ospedale Sacro Cuore Don Calabria, IBD Unit, Negrar di Valpolicella VR, Italy;(4)Fondazione IRCCS @D@Casa Sollievo della Sofferenza@D@, Division of Gastroenterology and Endoscopy, San Giovanni Rotondo FG, Italy;(5)School of Medicine Federico II of Naples, Gastroenterology- Department of Clinical Medicine and Surgery, Naples, Italy;(6)Ospedale Veris delli Ponti, UOC Gastroenterologia, Scorrano LE, Italy;(7)Fondazione IRCCS Cà Granda- Ospedale Maggiore Policlinico di Milano, Gastroenterology and Endoscopy Unit, Milan, Italy;(8)@D@San Filippo Neri@D@ Hospital, IBD Unit, Rome, Italy;(9)Azienda Ospedale Università di Padova- University of Padua, Gastroenterology Unit- Department of Surgery- Oncology and Gastroenterology, Padua, Italy;(10)IRCCS Policlinico San Martino- University of Genoa, Department of Internal Medicine, Genoa, Italy;(11)@D@IRCCS S. De Bellis@D@, Unità Operativa Semplice Dipartimentale - IBD, Castellaneta Grotte BA, Italy;(12)Sant@E@Andrea Hospital- Sapienza University of Rome, Digestive Disease Unit, Rome, Italy;(13)Ospedale @D@Dimiccoli@D@ Barletta, Gastroenterology and Endoscopy Unit, Barletta, Italy;(14)ULSS2 Marca Trevigiana- Ospedale Ca@E@Foncello, UOC Gastroenterologia, Treviso, Italy;(15)Fondazione IRCCS San Gerardo dei Tintori- University of Milano-Bicocca School of Medicine, Department of Gastroenterology- and Center for Autoimmune Liver Diseases- European Reference Network on Hepatological Diseases ERN RARE-LIVER, Monza, Italy;(16)AOUP P. Giaccone, UOC Gastroenterologia, Palermo, Italy;(17)Rho Hospital- ASST Rhodense, IBD Center- Gastroenterology Unit, Milan, Italy;(18)A.O.U.I. Policlinico G.B. Rossi & University of Verona, Gastroenterology Unit- Department of Medicine, Verona, Italy;(19)@D@Valduce@D@ Hospital, Gastroenterology Department, Como, Italy;(20)IG-IBD, Italian Group for the study of Inflammatory Bowel Disease, Florence, Italy;(21)IRCCS Sacro Cuore Don Calabria, Unità per la Ricerca Clinica, Negrar di Valpolicella VR, Italy;(22)ASST Lecco, Digestive Endoscopy and Gastroenterology Department, Lecco, Italy;(23)Fondazione IRCCS Cà Granda- Ospedale Maggiore Policlinico di Milano- Università degli Studi di Milano, Gastroenterology and Endoscopy Unit- Department of Pathophysiology and Transplantation, Milan, Italy;Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
P613: Dietary intervention as a novel tool to improve diagnostic accuracy of patency capsule in Crohn’s Disease patientsECCO'24Year: 2024
Authors: Talan Asher, A.(1,2)*;Lahat, A.(1,2);Ukashi, O.(1,2);Yablecovitch, D.(1,2);Engel, T.(1,2);Shachar, E.(1,2);Selinger, L.(1,2);Ungar, B.(1,2);Kopylov, U.(1,2);Eliakim, R.(1,2);Ben- Horin, S.(1,2);
(1)Sheba Medical Center, Gastroenterology, Ramat-Gan, Israel;(2)Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel;for the Israeli IBD Research Nucleus (IIRN)
P614: Endoscopic Electroincision Therapy for ChildrenECCO'24Year: 2024
Authors: Picoraro, J.(1)*;Shen, B.(2);
(1)Columbia University Irving Medical Center, Pediatrics, New York, United States;(2)Columbia University Irving Medical Center, Surgery, New York, United States;
P615: Clinical efficacy of accelerated 4-weekly vs. Conventional 8-weekly ustekinumab dosing in Inflammatory Bowel Disease: A single centre experience.ECCO'24Year: 2024
Authors: Lloyd, A.(1)*;Quarry, S.(2);Sugrue, K.(3);Gleeson, S.(3);O@E@Sullivan, G.(3);O@E@Sullivan, C.(3);Forde, G.(3);Doyle, M.(3);Moran, C.(4);Mcdonald, C.(3);Sheehan, D.(5);Buckley, M.(3);Iacucci, M.(3);McCarthy, J.(6);
(1)Mercy University Hospital, Gastroenterology Dept, Cork, Ireland;(2)University College Cork, Gastroenterology, Cork, Ireland;(3)Mercy University Hospital, Gastroenterology, Cork, Ireland;(4)Mercy Unversity Hospital, Gastroenteroloy, Cork, Ireland;(5)Mercy University Hopsital, Gastroenterology, Cork, Ireland;(6)Mercy University Hospital, Gastronenterology, Cork, Ireland;
P616: Prescribing practices of tofacitinib and preferences amongst high-risk patients in the UKECCO'24Year: 2024
Authors: Bishara, M.(1)*;Clarke, M.(1);Smith, R.(1);Roberts, C.(1);Kennedy, N.A.(1);Ahmad, T.(1);Goodhand, J.R.(1);
(1)Royal Devon University Healthcare NHS Foundation Trust, Gastroenterology, Exeter, United Kingdom;
P618: Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn@E@s Disease patientsECCO'24Year: 2024
Authors: Eroglu, Z.(1);Yilmaz, V.(2)*;Er, R.E.(2);Soykan, I.(2);Toruner, M.(3);
(1)Ankara University School of Medicine, Department of Internal Medicine, Ankara, Turkey;(2)Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey;(3)Ankara University Medical School- Ibni-sina Hospital, Department of Gastroenterology, Ankara, Turkey;
P620: A cost-effective Inflammatory Bowel Disease flare management pathway utilising rapid access intestinal ultrasound and nurse-led triage to achieve hospital avoidance with increased patient satisfactionECCO'24Year: 2024
Authors: Fernandes, R.(1)*;Khoo, E.(1);Harris, H.(1);Gilmore, R.(1);Khaing, M.(1);Begun, J.(1);An, Y.K.(1);
(1)Mater Hospital Brisbane, Gastroenterology, South Brisbane, Australia;Mater IBD Research Group
P621: Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case seriesECCO'24Year: 2024
Authors: Holvoet, T.(1,2)*;Verstockt, B.(3,4);Lenfant, M.(3);Julsgaard, M.(5,6);Drobne, D.(7);Thakor, A.(8);Gordon, H.(9);Molnar, T.(10);Savarino, E.V.(11);Ribaldone, D.G.(12);Miheller, P.(13);Vieujean, S.(14);Candel, I.(15);Menchen, L.(16);Bettenworth, D.(17,18);Eder, P.(19);Issachar, A.(20,21);Lobaton, T.(2);
(1)VITAZ, Gastroenterology, Sint Niklaas, Belgium;(2)Ghent University Hospital, Gastroenterology, Ghent, Belgium;(3)University Hospitals Leuven, Gastroenterology, Leuven, Belgium;(4)KU Leuven, Chronic Diseases and Metabolism, Leuven, Belgium;(5)Aarhus University Hospital, Hepatology and Gastroenterlogy, Aarhus, Denmark;(6)Aalborg University, Center for Molecular Predication of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(7)University Medical Centre Ljubiljana, Gastroenterology, Ljubiljana, Slovenia;(8)Addenbrooke@E@s Hospital- Cambridge University Hospitals NHS Foundation Trust, Gastroenterology, Cambridge, United Kingdom;(9)Royal London Hospital, Gastroenterology, London, United Kingdom;(10)University of Szeged- Szeged, Gastroenterology, Szeged, Hungary;(11)University of Padua - Azienda Ospedaliera di Padova, Gastroenterology, Padua, Italy;(12)University of Turin, Department of Medical Sciences- Division of Gastroenterology, Turin, Italy;(13)Semmelweis University, Gastroenterology, Budapest, Hungary;(14)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology, Liege, Belgium;(15)Udaondo`s Hospital- Buenos Aires City, Gastroenterology, Buenos Aires, Argentina;(16)Hospital General Universitario @D@Gregorio Marañón@D@ - IiSGM, Gastroenterology, Madrid, Spain;(17)University Hospital Münster, Gastroenterology, Münster, Germany;(18)CED, Schwerpunktpraxis, Münster, Germany;(19)Poznań University of Medical Sciences, Gastroenterology, Poznan, Poland;(20)Rabin Medical Center, The Liver Institute, Petah Tikva, Israel;(21)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;
